Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of Immunosuppression

This publication has 52 references indexed in Scilit:

• Immunity to Adeno-Associated Virus-Mediated Gene Transfer in a Random-Bred Canine Model of Duchenne Muscular Dystrophy
  Human Gene Therapy, 2007
• Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8
  Molecular Therapy, 2006
• Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman Primates
  Molecular Therapy, 2006
• What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
  Transplantation and Cellular Therapy, 2005
• Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
  Molecular Therapy, 2004
• PCR‐mediated Mutagenesis
  Published by Wiley ,2004
• Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
  Blood, 2004
• Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation
  Molecular Therapy, 2001
• Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
  Human Gene Therapy, 1999
• Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
  Cell, 1987